BATS BZX Real-Time Price
As of 12:42pm ET
| +0.05 / +0.28%|
The 5 analysts offering 12-month price forecasts for Momenta Pharmaceuticals Inc have a median target of 17.00, with a high estimate of 26.00 and a low estimate of 10.00. The median estimate represents a -3.41% decrease from the last price of 17.60.
The current consensus among 5 polled investment analysts is to Buy stock in Momenta Pharmaceuticals Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.